Advertisement
-
-
Efferocytosis in atherosclerosis
In this Review, Adkar and Leeper describe the mechanisms of programmed cell death and efferocytosis, discuss how efferocytosis becomes impaired in atherosclerosis and other cardiometabolic diseases, and suggest potential strategies to target these pathways for the treatment of atherosclerotic cardiovascular disease.
-
-
Anticoagulants
Anticoagulant drugs are used to prevent and treat thrombotic disorders in millions of patients worldwide. This Milestone plots the history of anticoagulant drugs, starting with the discovery and clinical trials of heparin and warfarin.
Trending - Altmetric
-
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
-
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
-
Strategies for the delivery of sex-based equity in cardiovascular clinical trials
-
Efferocytosis in atherosclerosis